Answers are grounded in this paper and cite their sources.
Virological surveillance reveals rapid genetic reassortment and severe neurological disease caused by avian influenza A(H5N1) in mammals, highlighting heightened pandemic risk.
Highly pathogenic avian influenza A(H5N1) viruses of clade 2.3.4.4b underwent an explosive geographic expansion in 2021, with the viruses being detected in wild birds and domestic poultry across Asia, Europe, and Africa. In 2022, viruses of this clade were detected in North America, signifying further intercontinental spread. Here, we show that the western movement of clade 2.3.4.4b was quickly followed by reassortment with local circulating viruses, resulting in the acquisition of novel polymerase gene cassettes. These reassortant A(H5N1) viruses are genotypically and phenotypically diverse, with many causing severe disease with dramatic neurologic involvement, in mammals. The proclivity of the current A(H5N1) 2.3.4.4b virus lineage to reassort and target the central nervous system warrants concerted planning to combat the spread and evolution of the virus within the continent and to mitigate the impact of a potential influenza pandemic that could originate from similar A(H5N1) reassortants.
No takes yet. Share an insight, caveat, or question.
Kandeil et al. (2022) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: